Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Activation-induced CD154 expression abrogates tolerance induced by apoptotic cellsPrajwal Gurung, Tamara A Kucaba, Thomas A Ferguson, et al.Virology|August 30, 2008
Interferon gamma is not required for recurrent herpetic stromal keratitisTammie L Keadle, Diane E Alexander, David A Leib, et al.Investigative Ophthalmology & Visual Science|February 1, 2022
Sensory Nerve Retraction and Sympathetic Nerve Innervation Contribute to Immunopathology of Murine Recurrent Herpes Stromal KeratitisHongmin Yun, Xiao-Tang Yin, Patrick M Stuart, et al.Ocular Immunology and Inflammation|March 2, 2006
Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain miceJohn Herndon, Therese S Gibler, Thomas A Ferguson, et al.Investigative Ophthalmology & Visual Science|February 26, 2003
The role of Fas-FasL in the development and treatment of ischemic retinopathyRamon Barreiro, Ramin Schadlu, John Herndon, et al.Journal of Neuroimmunology|December 2, 2008
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathwaysDaniel J J Carr, Bobbie A Austin, William P Halford, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitisDevin M West, Chelsea R Del Rosso, Xiao-Tang Yin, et al.The Journal of Clinical Investigation|November 3, 2007
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in miceJennifer Kelly, Aslam Ali Khan, Jiyi Yin, et al.Investigative Ophthalmology & Visual Science|July 4, 2013
Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degenerationHui Zhao, Jayeeta Roychoudhury, Teresa A Doggett, et al.Investigative Ophthalmology & Visual Science|February 19, 2010
Targeting immune privilege to prevent pathogenic neovascularizationJayeeta Roychoudhury, John M Herndon, Jiyi Yin, et al.Pageof 9